Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Acute Market Reports | PRODUCT CODE: 1542352

Cover Image

PUBLISHER: Acute Market Reports | PRODUCT CODE: 1542352

Transcatheter Heart Valve Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032

PUBLISHED:
PAGES: 176 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 6500
PDF (Enterprise License)
USD 9000

Add to Cart

The transcatheter heart valve (THV) market encompasses medical devices used in minimally invasive procedures to replace diseased heart valves. Transcatheter heart valve replacement is an alternative to traditional open-heart surgery, which typically requires a sternotomy and cardiopulmonary bypass. THV procedures, such as Transcatheter Aortic Valve Replacement (TAVR) or Transcatheter Mitral Valve Replacement (TMVR), involve the insertion of a bioprosthetic valve via a catheter, usually through a small incision in the leg or chest. This market has gained significant traction due to the advantages THV procedures offer over conventional surgery, particularly for high-risk patients who may not be candidates for open-heart surgery. Benefits include reduced procedural time, shorter hospital stays, quicker recovery, and lower risk of infection. THV procedures are primarily used to treat valve diseases like aortic stenosis and mitral regurgitation, conditions that are common in the elderly population. Transcatheter heart valve market is estimated to grow at a CAGR of 15.0% from 2024 to 2032. The growth of the THV market is driven by the aging global population and the increasing prevalence of valvular heart disease. Advances in THV technology, such as improved valve design and delivery systems, have expanded the treatable patient population and enhanced the safety and efficacy of these procedures.

Driver: Aging Population and Rising Prevalence of Heart Valve Diseases

The primary driver of the transcatheter heart valve (THV) market is the globally aging population combined with an increasing prevalence of heart valve diseases. As the population ages, the incidence of conditions like aortic stenosis and mitral regurgitation, which often require valve replacement, rises significantly. Older individuals, who are at a higher risk for these heart valve disorders, may not be ideal candidates for traditional open-heart surgery due to associated risks and longer recovery times. THV procedures, such as Transcatheter Aortic Valve Replacement (TAVR), offer a less invasive alternative with lower procedural risks, making them more suitable for elderly patients. This shift towards minimally invasive procedures has been further bolstered by improvements in THV technology and techniques, leading to better patient outcomes and expanded treatment options for high-risk patient groups.

Opportunity: Technological Advancements and Expanding Indications

A significant opportunity in the THV market lies in ongoing technological advancements and the expanding indications for these procedures. Recent developments in valve design, delivery systems, and procedural techniques have enhanced the safety, efficacy, and applicability of THV procedures. These advancements have led to a broader patient population being eligible for THV, including those with varying anatomical challenges and lower risk profiles. Furthermore, the potential expansion of THV applications beyond aortic valve replacement, such as into mitral and tricuspid valve interventions, opens up new avenues for growth in the market. The ongoing research and clinical trials aiming to establish the efficacy of THV procedures in a wider range of valvular heart diseases are poised to significantly broaden the market scope.

Restraint: High Cost of Procedures and Devices

However, a major restraint in the THV market is the high cost associated with the devices and procedures. The expenses incurred in developing and manufacturing advanced THV systems, combined with the costs of the specialized skills and infrastructure required for these procedures, contribute to their high price. This cost factor can be a significant barrier, particularly in regions with limited healthcare funding or inadequate insurance coverage. The economic burden of THV procedures may limit their accessibility and adoption, especially in developing countries where healthcare resources are constrained.

Challenge: Procedural Risks and Need for Long-term Data

A key challenge facing the THV market is managing the procedural risks associated with valve implantation and the need for long-term data on valve durability and patient outcomes. While THV procedures offer a less invasive alternative to surgery, they are not without risks, such as valve leakage, vascular complications, and the need for permanent pacemaker implantation. Addressing these safety concerns is crucial for patient confidence and the wider acceptance of THV as a standard treatment. Additionally, as THV procedures are relatively newer compared to traditional surgery, there is a need for more extensive long-term data to assess the durability of these valves and their long-term impact on patient health. This requirement for ongoing research and monitoring is critical in establishing the sustained efficacy and safety of THV procedures in the broader spectrum of heart valve diseases.

Market Segmentation by Application

In the market segmentation by application for the transcatheter heart valve (THV) market, including Transcatheter Aortic Valve, Transcatheter Pulmonary Valve, and Transcatheter Mitral Valve, each category demonstrates distinct market dynamics. The Transcatheter Aortic Valve segment has consistently generated the highest revenue. This is primarily due to the high prevalence of aortic stenosis among the elderly population and the well-established clinical efficacy of Transcatheter Aortic Valve Replacement (TAVR) procedures. TAVR has become a widely accepted treatment for aortic valve diseases, especially for patients at high or intermediate surgical risk, leading to its dominant revenue share in the THV market. In contrast, the Transcatheter Mitral Valve segment is projected to experience the highest Compound Annual Growth Rate (CAGR). Although it is a relatively newer area compared to aortic valve replacement, the growing focus on treating mitral valve disorders through less invasive techniques is driving rapid advancements and adoption in this segment. The increasing prevalence of mitral regurgitation and the expanding indications for transcatheter mitral valve replacement (TMVR) contribute to the growth potential of this segment.

Market Segmentation by Technology

Regarding market segmentation by technology, encompassing Balloon-Expanded Transcatheter Valve and Self-Expanded Transcatheter Valve, different trends are observed. The Balloon-Expanded Transcatheter Valve segment has traditionally been the revenue leader. These valves are widely used in TAVR procedures due to their precise placement control and effectiveness in various anatomical conditions. The predictability and established procedural techniques of balloon-expanded valves contribute to their higher adoption rate. However, the Self-Expanded Transcatheter Valve segment is expected to witness the highest CAGR. The growth in this segment is driven by the technological advancements in self-expanding valves, offering benefits like adaptability to diverse anatomical structures and lower profile delivery systems. The increasing preference for self-expanded valves in certain clinical scenarios, including patients with irregular valve anatomy, is fostering growth in this segment.

Regional Insights

In the geographic analysis of the transcatheter heart valve (THV) market, distinct trends and growth patterns are observed across various regions. In 2023, North America, particularly the United States, held the highest revenue share in the market, primarily due to the advanced healthcare infrastructure, high prevalence of heart valve diseases, and the early adoption of transcatheter procedures. The region's dominance was also supported by favorable reimbursement policies and the presence of leading THV manufacturers. However, from 2024 to 2032, the Asia-Pacific region is expected to exhibit the highest Compound Annual Growth Rate (CAGR). This projected growth can be attributed to the increasing prevalence of heart valve diseases in the aging population, improving healthcare facilities, and rising awareness of minimally invasive procedures in emerging economies like China and India. The expansion of healthcare infrastructure and the growing acceptance of advanced medical technologies in these countries are key drivers for the growth of the THV market in the Asia-Pacific region.

Competitive Trends

Regarding competitive trends and key strategies among the top players in the THV market, companies such as Boston Scientific Corporation, Bracco Group, Braile Biomedica, Direct Flow Medical, Edwards Lifesciences, JenaValve, St. Jude Medical, Symetis, ValveXchange, Inc were notable in 2023. Edwards Lifesciences, a pioneer in the field, maintained its leadership through continuous innovation and expansion of its transcatheter valve offerings. Medtronic also held a significant position in the market, focusing on technological advancements and expanding its global footprint. Boston Scientific made notable strides with its innovative valve systems and strategic acquisitions to enhance its product portfolio.

Historical & Forecast Period

This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Transcatheter Heart Valve market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Transcatheter Heart Valve market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Market Segmentation

Application

    • Transcatheter Aortic Valve
    • Transcatheter Pulmonary Valve
    • Transcatheter Mitral Valve

Technology

    • Balloon Expanded Transcatheter Valve
    • Self-Expanded Transcatheter Valve

Region Segment (2022-2032; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Transcatheter Heart Valve market?

What are the key investment pockets concerning product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2032.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Transcatheter Heart Valve market?

Which is the largest regional market for Transcatheter Heart Valve market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Transcatheter Heart Valve market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Transcatheter Heart Valve market worldwide?

Product Code: 507-07-24

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Transcatheter Heart Valve Market
  • 2.2. Global Transcatheter Heart Valve Market, By Application, 2023 (US$ Million)
  • 2.3. Global Transcatheter Heart Valve Market, By Technology, 2023 (US$ Million)
  • 2.4. Global Transcatheter Heart Valve Market, By Geography, 2023 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2023

3. Transcatheter Heart Valve Market: Competitive Analysis

  • 3.1. Market Positioning of Key Transcatheter Heart Valve Market Vendors
  • 3.2. Strategies Adopted by Transcatheter Heart Valve Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2023 Versus 2032

4. Transcatheter Heart Valve Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Transcatheter Heart Valve Market Value, 2022 - 2032, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 5.3. Market Segmentation
    • 5.3.1. Transcatheter Aortic Valve
    • 5.3.2. Transcatheter Pulmonary Valve
    • 5.3.3. Transcatheter Mitral Valve

6. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 6.3. Market Segmentation
    • 6.3.1. Balloon Expanded Transcatheter Valve
    • 6.3.2. Self-Expanded Transcatheter Valve

7. North America Transcatheter Heart Valve Market, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
  • 7.3. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
  • 7.4.Transcatheter Heart Valve Market: By Region, 2022-2032, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 7.4.1.1.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 7.4.1.2.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 7.4.1.3.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)

8. UK and European Union Transcatheter Heart Valve Market, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
  • 8.3. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
  • 8.4.Transcatheter Heart Valve Market: By Region, 2022-2032, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 8.4.1.1.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 8.4.1.2.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 8.4.1.3.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 8.4.1.4.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 8.4.1.5.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 8.4.1.6.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)

9. Asia Pacific Transcatheter Heart Valve Market, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
  • 9.3. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
  • 9.4.Transcatheter Heart Valve Market: By Region, 2022-2032, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 9.4.1.1.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 9.4.1.2.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 9.4.1.3.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 9.4.1.4.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 9.4.1.5.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 9.4.1.6.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)

10. Latin America Transcatheter Heart Valve Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
  • 10.3. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
  • 10.4.Transcatheter Heart Valve Market: By Region, 2022-2032, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 10.4.1.1.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 10.4.1.2.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 10.4.1.3.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)

11. Middle East and Africa Transcatheter Heart Valve Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
  • 11.3. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
  • 11.4.Transcatheter Heart Valve Market: By Region, 2022-2032, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 11.4.1.1.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 11.4.1.2.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Transcatheter Heart Valve Market: By Application, 2022-2032, USD (Million)
        • 11.4.1.3.2. Transcatheter Heart Valve Market: By Technology, 2022-2032, USD (Million)

12. Company Profile

  • 12.1. Boston Scientific Corporation
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Bracco Group
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Braile Biomedica
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Direct Flow Medical
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Edwards Lifesciences
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. JenaValve, St. Jude Medical
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Symetis
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. ValveXchange, Inc
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Other Notable Players
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
Product Code: 507-07-24

List of Tables

  • TABLE 1 Global Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 2 Global Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 3 North America Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 4 North America Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 5 U.S. Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 6 U.S. Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 7 Canada Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 8 Canada Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 9 Rest of North America Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 10 Rest of North America Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 11 UK and European Union Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 12 UK and European Union Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 13 UK Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 14 UK Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 15 Germany Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 16 Germany Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 17 Spain Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 18 Spain Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 19 Italy Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 20 Italy Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 21 France Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 22 France Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 23 Rest of Europe Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 24 Rest of Europe Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 25 Asia Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 26 Asia Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 27 China Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 28 China Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 29 Japan Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 30 Japan Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 31 India Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 32 India Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 33 Australia Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 34 Australia Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 35 South Korea Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 36 South Korea Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 37 Latin America Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 38 Latin America Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 39 Brazil Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 40 Brazil Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 41 Mexico Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 42 Mexico Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 43 Rest of Latin America Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 44 Rest of Latin America Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 45 Middle East and Africa Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 46 Middle East and Africa Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 47 GCC Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 48 GCC Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 49 Africa Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 50 Africa Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Transcatheter Heart Valve Market By Application, 2022-2032, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Transcatheter Heart Valve Market By Technology, 2022-2032, USD (Million)

List of Figures

  • FIG. 1 Global Transcatheter Heart Valve Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Transcatheter Heart Valve Market: Quality Assurance
  • FIG. 5 Global Transcatheter Heart Valve Market, By Application, 2023
  • FIG. 6 Global Transcatheter Heart Valve Market, By Technology, 2023
  • FIG. 7 Global Transcatheter Heart Valve Market, By Geography, 2023
  • FIG. 8 Market Geographical Opportunity Matrix - Global Transcatheter Heart Valve Market, 2023

FIG. 9Market Positioning of Key Transcatheter Heart Valve Market Players, 2023

FIG. 10Global Transcatheter Heart Valve Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

  • FIG. 11 Global Transcatheter Heart Valve Market, By Application, 2023 Vs 2032, %
  • FIG. 12 Global Transcatheter Heart Valve Market, By Technology, 2023 Vs 2032, %
  • FIG. 13 U.S. Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
  • FIG. 14 Canada Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
  • FIG. 15 Rest of North America Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
  • FIG. 16 UK Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
  • FIG. 17 Germany Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
  • FIG. 18 Spain Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
  • FIG. 19 Italy Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
  • FIG. 20 France Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
  • FIG. 21 Rest of Europe Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
  • FIG. 22 China Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
  • FIG. 23 Japan Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
  • FIG. 24 India Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
  • FIG. 25 Australia Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
  • FIG. 26 South Korea Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
  • FIG. 27 Rest of Asia Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
  • FIG. 28 Brazil Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
  • FIG. 29 Mexico Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
  • FIG. 30 Rest of Latin America Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
  • FIG. 31 GCC Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
  • FIG. 32 Africa Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
  • FIG. 33 Rest of Middle East and Africa Transcatheter Heart Valve Market (US$ Million), 2022 - 2032
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!